IDI-ARABA, LAGOS STATE— In a significant increase to Nigeria’s tertiary healthcare capability, the Shell Nigeria Exploration and Production Company (SNEPCo) and the Nigerian National Petroleum Business (NNPC) Limited Joint Endeavor have actually donated a suite of innovative lung diagnostic devices to the Lagos University Mentor Health Center (LUTH).
The donation, which includes an Endobronchial Ultrasound (EBUS) system and a Body Plethysmograph, positions LUTH as a premier hub for high-precision breathing care in West Africa.
The main handover event, held at the LUTH Idi-Araba school, was explained by health stakeholders as a landmark occasion that bridges the space between traditional clinical evaluation and technology-enabled evidence-based medication.
Precision Diagnostics for Lung Cancer
The EBUS system is a game-changer for oncology in Nigeria. Generally, lung biopsies were frequently intrusive or did not have the precision needed for accurate staging.
The new EBUS technology allows clinicians to perform real-time assisted biopsies of the lungs and lymph nodes, which is necessary for figuring out the specific treatment course for lung cancer patients.
Medical Capabilities of the New Systems:
-
EBUS System: Facilitates minimally intrusive, real-time imaging of the respiratory tracts and surrounding structures, enabling precise staging of thoracic malignancies.
-
Body Plethysmograph: Frequently described as a “body box,” this devices determines functional recurring capacity and overall lung capability, supplying the most accurate diagnosis for asthma, COPD, and restrictive lung illness.
Read also: UNILORIN and NNPCL form tactical committee for West Africa’s very first engineering centre of excellence.
A Shift Toward Evidence-Based Care
Speaking at the event, SNEPCo Managing Director Ronald Adams, represented by General Manager of Communications, Abubakar Ahmed, emphasised that the intervention represents a fundamental shift in Nigeria’s medical landscape.
“It is a shift from constrained diagnostics to evidence-based, technology-enabled respiratory care,” Adams specified.
He noted that the devices empowers clinicians to practice at the full height of their training, making sure that clients no longer need to take a trip abroad for specialised pulmonary tests.
The Chief Upstream Investment Officer of NNPC Upstream Investment Management Solutions (NUIMS), Olanrewaju Igandan, reaffirmed the JV’s commitment to social financial investment.
Represented by Edith Bunmi-Lawson, Igandan kept in mind that national development is insufficient without resistant health care organizations.
“This effort reflects our belief that sustainable national development surpasses energy production. It has to do with improving lives and purchasing systems that sustain,” he mentioned.
Landmark Influence On Public Health
The Chief Medical Director of LUTH, Teacher Wasiu Lanre Adeyemo, represented by the Deputy Chairman of the Medical Advisory Committee, Prof. Babawale, thanked the donors for offering access to specialised care within the public sector.
He noted that such advanced devices is seldom offered in public hospitals, and its arrival will significantly enhance the outcomes for patients with intricate breathing ailments across Nigeria.
As LUTH incorporates these systems into its everyday clinical operations, the health center anticipates a surge in recommendations from across the nation, enhancing its position as a centre of excellence in medical research study and training.